Abstract
Advancements in science and technology has created an expectation and demand on research and innovation to address some of the greatest societal challenges, particularly in the health and biomedical fields. There is an inherent promise associated with the potential of breakthrough technologies, particularly when combined with quality health-related data, to deliver significant improved health outcomes globally. However, science and innovation alone are not sufficient to achieve societal transformation towards global health. There is an observed reluctance to operationalize the use of existing data, mainly due to privacy and security concerns, as well as a palpable apprehension around how, for what purpose, and by whom data will be used. Research and innovation need to be supported by behavior and attitude change in order to foster inclusive participation and effective societal uptake of the resulting solutions. This chapter explores how the principles of Responsible Research and Innovation can be applied to provide a legally supported, inclusive, and sustainable approach to operationalizing the use of existing data in support of health-related innovations. By incorporating a deliberative and responsive process to citizen science practices, the root causes underlying this observed reluctance can be identified and addressed. The overall aim is to gain a fundamental understanding of the real and perceived barriers to utilizing data for research and innovation purposes, which can then be used to proffer solutions to create a responsive and inclusive culture to sustainably support the ongoing responsible use of data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
- 2.
Murray et al. (2020), pp. 1135–1159.
- 3.
World Health Organization (2022).
- 4.
Florent (2020), p. 1129.
- 5.
- 6.
- 7.
- 8.
O’Neill (2016).
- 9.
- 10.
- 11.
- 12.
Yu (2016), pp. 611–635.
- 13.
World Health Organization (2020a).
- 14.
Houe (2019), pp. 1–8.
- 15.
Yu (2016), pp. 611–635.
- 16.
Yu (2016), pp. 611–635.
- 17.
Kaye and Hawkins (2014), pp. 1–8.
- 18.
Dias and Duarte (2015), pp. 230–236.
- 19.
- 20.
Dunn et al. (2018), pp. 429–448.
- 21.
Piwek et al. (2016), pp. 1–9.
- 22.
- 23.
Hemerly (2013), pp. 25–31.
- 24.
Hemingway et al. (2018), pp. 1481–1495.
- 25.
See, e.g., Seh et al. (2020), p. 133.
- 26.
NEJM Catalyst (2018).
- 27.
Hemerly (2013), pp. 25–31.
- 28.
European Commission (2018).
- 29.
- 30.
See, e.g., European Commission (2020); European Commission (2017); Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation); Directive (EU) 2019/790 of the European Parliament and of the Council of 17 April 2019 on copyright and related rights in the Digital Single Market and amending Directives 96/9/EC and 2001/29/EC (Text with EEA relevance.) PE/51/2019/REV/1; Proposal for a Regulation of the European Parliament and of the Council on harmonised rules on fair access to and use of data (Data Act) CON/2022/68 final.
- 31.
European Commission (2022a).
- 32.
European Commission (2022b).
- 33.
- 34.
- 35.
- 36.
Halperin (2011), pp. 45–76.
- 37.
Visschers and Siegrist (2008), pp. 156–167.
- 38.
Strasser et al. (2019), pp. 52–76.
- 39.
RRI Tools, https://www.rri-tools.eu/about-rri. Accessed 4 September 2022.
- 40.
Macq et al. (2020), pp. 489–512.
- 41.
Zwart et al. (2014), p. 11.
- 42.
Von Schomberg and Blok (2021), pp. 309–323.
- 43.
- 44.
Smallman (2018), pp. 241–253.
- 45.
Stilgoe et al. (2013), pp. 1568–1580.
- 46.
Novitzky et al. (2020), pp. 39–41.
- 47.
- 48.
- 49.
Miller and Sim (2004), pp. 116–126.
- 50.
- 51.
Dryzek et al. (2019), pp. 1144–1146.
- 52.
OECD (2020).
- 53.
Bächtiger et al. (2018).
- 54.
Ercan et al. (2019), pp. 19–36.
- 55.
Von Schomberg (2013), pp. 51–74.
- 56.
Irwin (2006), pp. 299–320.
- 57.
- 58.
- 59.
Hahn et al. (2017), pp. 290–295.
- 60.
- 61.
- 62.
- 63.
Ribeiro et al. (2018), pp. 316–331.
- 64.
Griggs et al. (2014).
- 65.
- 66.
Bajmócy and Pataki (2019).
- 67.
Hartley et al. (2017), pp. 361–377.
- 68.
Hartley et al. (2017), pp. 361–377.
- 69.
Van Panhuis et al. (2014), pp. 1–9.
- 70.
Andanda (2013), pp. 140–177.
- 71.
Günther et al. (2017), pp. 191–209.
- 72.
Hulsen (2020), p. 3046.
References
Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K (2007) The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370(9603):1929–1938
Adibuzzaman M, DeLaurentis P, Hill J, Benneyworth BD (2017) Big data in healthcare–the promises, challenges and opportunities from a research perspective: a case study with a model database. In: AMIA annual symposium proceedings. p 384
Åm H (2019) Limits of decentered governance in science-society policies. J Responsible Innov 6(2):163–178
Andanda P (2013) Managing intellectual property rights over clinical trial data to promote access and benefit sharing in public health. IIC-Int Rev Intellect Prop Compet Law 44(2):140–177
Appari A, Johnson ME (2010) Information security and privacy in healthcare: current state of research. Int J Internet Enterp Manag 6(4):279–314
Bächtiger A, Dryzek JS, Mansbridge J, Warren ME (eds) (2018) The oxford handbook of deliberative democracy. Oxford University Press, Oxford
Bajmócy Z, Pataki G (2019) Responsible research and innovation and the challenges of co-creation. In: Bammé A, Getzinger G (eds) Yearbook 2018 of the institute for advanced studies on science, technology and society. Profil Verlag, München–Wien
Barrows RC Jr, Clayton PD (1996) Privacy, confidentiality, and electronic medical records. J Am Med Inform Assoc 3(2):139–148
Bax R et al (2001) Surveillance of antimicrobial resistance—what, how and whither? Clin Microbiol Infect 7(6):316–325
Blok V, Lemmens P (2015) The emerging concept of responsible innovation. Three reasons why it is questionable and calls for a radical transformation of the concept of innovation. In: Responsible innovation 2: concepts, approaches, and applications. pp 19–35
Bonander J, Gates S (2010) Public health in an era of personal health records: opportunities for innovation and new partnerships. J Med Internet Res 12(3):e1346
Boydell V, McMullen H, Cordero J, Steyn P, Kiare J (2019) Studying social accountability in the context of health system strengthening: innovations and considerations for future work. Health Res Policy Syst 17(34):1–6
Brown T, Wyatt J (2010) Design thinking for social innovation. Dev Outreach 12(1):29–43
Chhanabhai P, Holt A (2007) Consumers are ready to accept the transition to online and electronic records if they can be assured of the security measures. Medscape Gen Med 9(1):8
Ciasullo MV, Carli M, Lim WM, Palumbo R (2022) An open innovation approach to co-produce scientific knowledge: an examination of citizen science in the healthcare ecosystem. Eur J Innov Manag 25(6):365–392
Coorevits P, Sundgren M, Klein GO, Bahr A, Claerhout B, Daniel C, Dugas M, Dupont D, Schmidt A, Singleton P, De Moor G (2013) Electronic health records: new opportunities for clinical research. J Intern Med 274(6):547–560
Den Broeder L, Devilee J, Van Oers H, Schuit AJ, Wagemakers A (2018) Citizen Science for public health. Health Promot Int 33(3):505–514
Dias JA, Duarte P (2015) Big data opportunities in healthcare. How can medical affairs contribute. Rev Port Farmacoter 7(4):230–236
Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, Brito JP, Boehmer K, Hasan R, Firwana B, Erwin P (2014) Patient engagement in research: a systematic review. BMC Health Serv Res 14(1):1–9
Dryzek JS, Bächtiger A, Chambers S, Cohen J, Druckman JN, Felicetti A, Fishkin JS, Farrell DM, Fung A, Gutmann A, Landemore H (2019) The crisis of democracy and the science of deliberation. Science 363(6432):1144–1146
Dunn J, Runge R, Snyder M (2018) Wearables and the medical revolution. Pers Med 15(5):429–448
Elwyn G, Frosch DL, Kobrin S (2015) Implementing shared decision-making: consider all the consequences. Implement Sci 11(1):1–10
Ercan SA, Hendriks CM, Dryzek JS (2019) Public deliberation in an era of communicative plenty. Policy Polit 47(1):19–36
European Commission (2017) Building a European data economy. Brussels 10.1.2017 COM (2017) 9 final.
European Commission (2018) Study on emerging issues of data ownership, interoperability, (re-)usability and access to data, and liability—final report
European Commission (2020) European data strategy. Brussels, 19.2.2020 COM (2020) 66 final
European Commission (2022a) European data strategy. https://commission.europa.eu/strategy-and-policy/priorities-2019-2024/europe-fit-digital-age/european-data-strategy_en. Accessed 27 Dec 2022a
European Commission (2022b) European data governance act. https://digital-strategy.ec.europa.eu/en/policies/data-governance-act. Accessed 27 Dec 2022b
Florent V (2020) Global health: time for radical change. Lancet 396(874):1129
Frahm N, Doezema T, Pfotenhauer S (2022) Fixing technology with society: the coproduction of democratic deficits and responsible innovation at the OECD and the European commission. Sci Technol Human Values 47(1):174–216
Goldman DP, Shang B, Bhattacharya J, Garber AM, Hurd M, Joyce GF, Lakdawalla DN, Panis C, Shekelle PG (2005) Consequences of health trends and medical innovation for the future elderly: when demographic trends temper the optimism of biomedical advances, how will tomorrow’s elderly fare? Health Aff 24(Suppl2):W5-R5
Griggs S, Norval A, Wagenaar H (2014) Practices of freedom. Decentred governance, conflict and democratic participation. Cambridge University Press, Cambridge
Groves P, Kayyali B, Knott D, Kuiken SV (2016) The ‘big data’ revolution in healthcare: accelerating value and innovation. McKinsey & Company, Center for US Health System Reform Business Technology Office, pp 1–20
Günther WA, Mehrizi MHR, Huysman M, Feldberg F (2017) Debating big data: a literature review on realizing value from big data. J Strateg Inf Syst 26(3):191–209
Haas S, Wohlgemuth S, Echizen I, Sonehara N, Müller G (2011) Aspects of privacy for electronic health records. Int J Med Inf 80(2):e26–e31
Hahn DL, Hoffmann AE, Felzien M, LeMaster JW, Xu J, Fagnan LJ (2017) Tokenism in patient engagement. Fam Pract 34(3):290–295
Halperin JL (2011) Law in books and law in action: the problem of legal change. Maine Law Rev 64(1):45–76
Hartley S, Pierce W, Taylor A (2017) Against the tide of depoliticisation: the politics of research governance. Policy Polit 45(3):361–377
Hemerly J (2013) Public policy considerations for data-driven innovation. Computer 46(6):25–31
Hemingway H, Asselbergs FW, Danesh J, Dobson R, Maniadakis N, Maggioni A, Van Thiel GJ, Cronin M, Brobert G, Vardas P, Anker SD (2018) Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Eur Heart J 39(16):1481–1495
Heyen NB, Gardecki J, Eidt-Koch D, Schlangen M, Pauly S, Eickmeier O, Wagner T, Bratan T (2022) Patient science: citizen science involving chronically ill people as co-researchers. J Particip Res Methods 3(1):1–24
Hickey S, King S (2016) Understanding social accountability: politics, power and building new social contracts. J Dev Stud 52(8):1225–1240
Holden RJ, Karsh BT (2009) A theoretical model of health information technology usage behaviour with implications for patient safety. Behav Inf Technol 28(1):21–38
Houe H, Nielsen SS, Nielsen LR, Ethelberg S, Mølbak K (2019) Opportunities for improved disease surveillance and control by use of integrated data on animal and human health. Front Vet Sci 6(301):1–8
Howe N, Giles E, Newbury-Birch D, McColl E (2018) Systematic review of participants’ attitudes towards data sharing: a thematic synthesis. J Health Serv Res Policy 23(2):123–133
Hulsen T (2020) Sharing is caring—data sharing initiatives in healthcare. Int J Environ Res Public Health 17(9):3046
Irwin A (2001) Constructing the scientific citizen: Science and democracy in the biosciences. Public Underst Sci 10(1):1–18
Irwin A (2006) The politics of talk: coming to terms with the “new” scientific governance. Soc Stud Sci 36(2):299–320
Issa NT, Byers SW, Dakshanamurthy S (2014) Big data: the next frontier for innovation in therapeutics and healthcare. Expert Rev Clin Pharmacol 7(3):293–298l
Jakku E, Taylor B, Fleming A, Mason C, Fielke S, Sounness C, Thorburn P (2019) “If they don’t tell us what they do with it, why would we trust them?” Trust, transparency and benefit-sharing in smart farming. NJAS—Wagening J Life Sci 90:1–13
Jelsma J (2006) Designing ‘Moralized’ products. In: Verbeek PP, Slob A (eds) User behavior and technology development: shaping sustainable relations between consumers and technologies. Springer, Berlin
Jirotka M, Procter R, Hartswood M, Slack R, Simpson A, Coopmans C, Hinds C, Voss A (2005) Collaboration and trust in healthcare innovation: The eDiaMoND case study. Comput Support Coop Work (CSCW) 14(4):369–398
Johnston M (2006) Good governance: rule of law, transparency, and accountability. United Nations Public Administration Network, New York, pp 1–32
Joshi A (2017) Legal empowerment and social accountability: Complementary strategies toward rights-based development in health? World Dev 99:160–172
Kalra D, Stroetmann V, Sundgren M, Dupont D, Schlünder I, Thienpont G, Coorevits P, De Moor G (2017) The European institute for innovation through health data. Learn Health Syst 1(1):1–8
Kaye J, Hawkins N (2014) Data sharing policy design for consortia: challenges for sustainability. Genome Med 6(1):1–8
Kruse CS, Smith B, Vanderlinden H, Nealand A (2017) Security techniques for the electronic health records. J Med Syst 41(8):1–9
Lehoux P, Williams-Jones B, Miller F, Urbach D, Tailliez S (2008) What leads to better health care innovation? Arguments for an integrated policy-oriented research agenda. J Health Serv Res Policy 13(4):251–254
Macq H, Tancoigne É, Strasser BJ (2020) From deliberation to production: public participation in science and technology policies of the European Commission (1998–2019). Minerva 58(4):489–512
Malin BA, Emam KE, O’Keefe CM (2013) Biomedical data privacy: problems, perspectives, and recent advances. J Am Med Inform Assoc 20(1):2–6
Miller RH, Sim I (2004) Physicians’ use of electronic medical records: barriers and solutions. Health Aff 23(2):116–126
Murray CJ, Abbafati C, Abbas KM, Abbasi M, Abbasi-Kangevari M, Abd-Allah F, Abdollahi M, Abedi P, Abedi A, Abolhassani H, Aboyans V (2020) Five insights from the global burden of disease study 2019. Lancet 396(10258):1135–1159
NEJM Catalyst (2018) Healthcare big data and the promise of value-based care. NEJM Catalyst 4(1)
Novitzky P, Bernstein MJ, Blok V, Braun R, Chan TT, Lamers W, Loeber A, Meijer I, Lindner R, Griessler E (2020) Improve alignment of research policy and societal values. Science 369(6499):39–41
Organization for Economic Cooperation and Development (2021) Report on the implementation of the recommendation of the council concerning guidelines governing the protection of privacy and transborder flows of personal data, C 42. https://one.oecd.org/document/C(2021)42/en/pdf. Accessed 28 Dec 2022
O'Neill J (2016) Tackling drug-resistant infections globally: final report and recommendations. https://amrreview.org/sites/default/files/160518_Final%20paper_with%20cover.pdf. Accessed 21 Dec 2022
Organization for Economic Cooperation and Development (2020). Innovative citizen participation and new democratic institutions: catching the deliberative wave. https://www.oecdilibrary.org/sites/339306daen/index.html?itemId=/content/publication/339306da-en. Accessed 4 Jan 2023
Owen R, von Schomberg R, Macnaghten P (2021) An unfinished journey? Reflections on a decade of responsible research and innovation. J Responsible Innov 8(2):217–233
Owen R, Pansera M (2019) Responsible innovation and responsible research and innovation. Handbook on science and public policy. pp 26–48
Park E, Kim KJ (2014) An integrated adoption model of mobile cloud services: exploration of key determinants and extension of technology acceptance model. Telemat Inform 31(3):376–385
Pisani E, AbouZahr C (2010) Sharing health data: good intentions are not enough. Bull World Health Organ 88(6):462–466
Piwek L, Ellis DA, Andrews S, Joinson A (2016) The rise of consumer health wearables: promises and barriers. PLoS Med 13(2):1–9
Proksch D, Busch-Casler J, Haberstroh MM, Pinkwart A (2019) National health innovation systems: clustering the OECD countries by innovative output in healthcare using a multi indicator approach. Res Policy 48(1):169–179
Ribeiro B, Bengtsson L, Benneworth P, Bührer S, Castro-Martínez E, Hansen M, Jarmai K, Lindner R, Olmos-Peñuela J, Ott C, Shapira P (2018) Introducing the dilemma of societal alignment for inclusive and responsible research and innovation. J Responsible Innov 5(3):316–331
Roberts JP, Fisher TR, Trowbridge MJ, Bent C (2016) A design thinking framework for healthcare management and innovation. Healthcare 4(1):11–14
Saura JR, Ribeiro-Soriano D, Palacios-Marqués D (2021) From user-generated data to data-driven innovation: a research agenda to understand user privacy in digital markets. Int J Inf Manage 60:1–13
Seh AH, Zarour M, Alenezi M, Sarkar AK, Agrawal A, Kumar R, Ahmad Khan R (2020) Healthcare data breaches: insights and implications. Healthcare 8(2):133
Shay LA, Lafata JE (2015) Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making 35(1):114–131
Smallman, M., (2018) Citizen science and responsible research and innovation. UCL Press, pp. 241–253.
Stilgoe J, Owen R, Macnaghten P (2013) Developing a framework for responsible innovation. Res Policy 42(9):1568–1580
Stockdale J, Cassell J, Ford E (2018) “Giving something back”: a systematic review and ethical enquiry into public views on the use of patient data for research in the United Kingdom and the Republic of Ireland. Wellcome Open Res 3(6):1–25
Strasser B, Baudry J, Mahr D, Sanchez G, Tancoigne E (2019) “Citizen science”? Rethinking science and public participation. Sci Technol Stud 32:52–76
Thakur R, Hsu SH, Fontenot G (2012) Innovation in healthcare: Issues and future trends. J Bus Res 65(4):562–569
Van Oudheusden M (2014) Where are the politics in responsible innovation? European governance, technology assessments, and beyond. J Responsible Innov 1(1):67–86
Van Panhuis WG, Paul P, Emerson C, Grefenstette J, Wilder R, Herbst AJ, Heymann D, Burke DS (2014) A systematic review of barriers to data sharing in public health. BMC Public Health 14(1):1–9
Visschers VH, Siegrist M (2008) Exploring the triangular relationship between trust, affect, and risk perception: a review of the literature. Risk Manag 10(3):156–167
Von Schomberg R (2013) A vision of responsible research and innovation. In: Owen R, Bessant J, Heintz M (eds) Responsible innovation: managing the responsible emergence of science and innovation in society. Wiley, London, pp 51–74
Von Schomberg L, Blok V (2021) Technology in the age of innovation: responsible innovation as a new subdomain within the philosophy of technology. Philos Technol 34:309–323
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet 396(10258):1204–1222
World Health Organization (2015). Global action plan on antimicrobial resistance. https://www.who.int/antimicrobial-resistance/global-action-plan/en/. Accessed 21 Aug 2022
World Health Organization (2020b) Global antimicrobial resistance and use surveillance system (GLASS) report. https://apps.who.int/iris/bitstream/handle/10665/332081/9789240005587-eng.pdf. Accessed 21 Aug 2022
World Health Organization (2020a) Challenges to tackling antimicrobial resistance economic and policy responses: economic and policy responses. OECD Publishing
World Health Organization (2022) World Health Organization Strategy (2022–2026) for the national action plan for health security. https://www.who.int/publications/i/item/9789240061552. Accessed 10 Dec 2022
Yu H (2016) Redefining responsible research and innovation for the advancement of biobanking and biomedical research. J Law Biosci 3(3):611–635
Zwart H, Landeweerd L, van Rooij A (2014) Adapt or perish? Assessing the recent shift in the European research funding arena from ‘ELSA’ to ‘RRI.’ Life Sci Soc Policy 10(1):11
Acknowledgements
This research was supported by a Novo Nordisk Foundation grant for a scientifically independent Collaborative Research Program in Biomedical Innovation Law (grant agreement number NNF17SA0027784) and by a grant from the Center for Digital Life Norway and the Research Council of Norway (grant agreement number 294594).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yu, H. (2024). Operationalizing the Use of Existing Data in Support of Biomedical Research and Innovation: An Inclusive and Sustainable Approach. In: Corrales Compagnucci, M., Minssen, T., Fenwick, M., Aboy, M., Liddell, K. (eds) The Law and Ethics of Data Sharing in Health Sciences. Perspectives in Law, Business and Innovation. Springer, Singapore. https://doi.org/10.1007/978-981-99-6540-3_5
Download citation
DOI: https://doi.org/10.1007/978-981-99-6540-3_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-6539-7
Online ISBN: 978-981-99-6540-3
eBook Packages: Law and CriminologyLaw and Criminology (R0)